Levofloxacin 0.5%

DRUG3 trials

Sponsors

Indiana University School of Medicine, Santen Pharmaceutical Co., Ltd., Hayder Adnan Fawzi

Conditions

CataractCataract SurgeryCutaneous Leishmaniasis

Phase 2

Intralesional Injection of Levofloxacin for the Management of Cutaneous Leishmaniasis

RecruitingNCT06797544

Hayder Adnan FawziCutaneous Leishmaniasis

Start: 2025-02-09End: 2025-11-01Target: 40Updated: 2025-09-30

Phase 3

Study of DE-108 Ophthalmic Solution in Patients Who Are Scheduled for Cataract Surgery

CompletedNCT02573610

Santen Pharmaceutical Co., Ltd.Cataract Surgery

Start: 2015-09-21End: 2017-03-31Updated: 2017-10-12

Phase 4

Penetrance of Third Generation Fluoroquinolones in Eyes With Functioning Filtering Blebs

CompletedNCT00392275

Indiana University School of MedicineCataract

Start: 2002-11-30End: 2006-05-31Target: 48Updated: 2013-04-10